Contrast-Enhanced EUS for Differential Diagnosis of Pancreatic Masses: A Meta-Analysis
Authors:
Open Access
- 6 March 2019
- journal article
- research article
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2019, 1-9
Abstract
Background. Though methods for the diagnosis of pancreatic masses are various, such as ultrasonography (US), computed tomography (CT), endoscopic ultrasonography (EUS), and contrast-enhanced computed tomography (CE-CT), their sensitivity, specificity, and accuracy are not quite satisfying. Contrast-enhanced endoscopic ultrasonography (CE-EUS), as a new technique, has its own unique advantages in diagnosing pancreatic disease. However, its sensitivity, specificity, and accuracy are still controversial. Objective. To evaluate the accuracy of CE-EUS for differential diagnosis between benign and malignant pancreatic mass lesions. Design. Eighteen relevant articles systemically searched from PubMed, Web of Science, Ovid, Scopus, and MEDLINE were selected. The pooled results were calculated in a fixed effects model. Main Outcome Measurement. The pooled sensitivity, specificity, positive likelihood ratio (LR), negative likelihood ratio, diagnostic odds ratio (OR), and summary receiver operating characteristic (SROC) curve. Results. The pooled sensitivity, specificity, and diagnostic odds ratio of CE-EUS for the differential diagnosis of pancreatic adenocarcinomas were 0.91 (95% confidence interval (CI), 0.89-0.93), 0.86 (95% CI, 0.83-0.89), and 69.50 (95% CI, 48.89-98.80), respectively. The SROC area under the curve was 0.9545. The subgroup analysis based on excluding the outliers showed that the heterogeneity was eliminated and the pooled sensitivity and specificity were 0.92 (95% CI, 0.90-0.93) and 0.87 (95% CI, 0.84-0.89), respectively. The SROC area under the curve was 0.9569. Conclusion. CE-EUS is a useful method to distinguish pancreatic adenocarcinoma from other pancreatic diseases. Compared with EUS elastography, it has higher specificity. However, it is still not superior to pathological diagnosis for the identification of pancreatic carcinomas.Keywords
This publication has 42 references indexed in Scilit:
- Quantitative low mechanical index contrast-enhanced endoscopic ultrasound for the differential diagnosis of chronic pseudotumoral pancreatitis and pancreatic cancerBMC Gastroenterology, 2013
- EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II studyGastrointestinal Endoscopy, 2012
- Contrast-enhanced endoscopic ultrasonographyWorld Journal of Gastroenterology, 2011
- Accuracy of contrast-enhanced harmonic EUS with a second-generation perflutren lipid microsphere contrast agent (with video)Gastrointestinal Endoscopy, 2011
- Combined contrast-enhanced power Doppler and real-time sonoelastography performed during EUS, used in the differential diagnosis of focal pancreatic masses (with videos)Gastrointestinal Endoscopy, 2010
- Contrast-enhanced harmonic endoscopic ultrasound in solid lesions of the pancreas: results of a pilot studyEndoscopy, 2010
- Contrast enhanced endoscopic ultrasound: More than just a fancy DopplerWorld Journal of Gastrointestinal Endoscopy, 2010
- Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasoundJournal of Cancer Research and Clinical Oncology, 2007
- Contrast-Enhanced Endosonographic Doppler Spectrum Analysis Is Helpful in Discrimination Between Focal Chronic Pancreatitis and Pancreatic CancerPancreas, 2007
- Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitisGastrointestinal Endoscopy, 2005